Certified by Founder Lodge
Cure51
France - Paris
START UP
1 Disclosed Funding Rounds $16,260,975
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 20 ,2024 | Seed | $16,260,975 |
Life Extension Ventures
Hitachi Ventures
Sofinnova Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
